Global Bifidobacterium Longum Market

Bifidobacterium Longum Comprehensive Study by Type (0.2g/Piece, 0.25g/Piece), Application (Medicine, Others), Distribution Channel (Online, Offline), Varieties (Sub-acute experimental, Acute) Players and Region - Global Market Outlook to 2027

Bifidobacterium Longum Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Bifidobacterium Longum Market?

Herbal remedies have become popular, due in part to the lower risk of adverse reactions. Longum is a multifunctional probiotic that is effective in alleviating gastrointestinal, immunological, and infectious diseases. Existing evidence implies that the multifunctional effects are attributed to its ability to stabilize gut microbiota and improve the intestinal environment. WHO revealed that 5.2 million children under five of age die every year due to preventable diseases such as diarrhea, malaria, and pneumonia. In Malaysia, reported cases of diarrhea and acute gastroenteritis have been observed to occur throughout the year, with rotavirus-associated diarrhea being the most prevalently identified gastrointestinal disorder.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBioGaia AB (Sweden), Mystic Pharmaceuticals Inc (United States), Hanson Ltd (United Kingdom), Biofodan A/S (Denmark), BioCare Copenhagen ApS(Denmark), Danisco A/S (Denmark), Danone SA (France) and Deerland Probiotics & Enzymes (United States)


The market study is being classified by Type (0.2g/Piece and 0.25g/Piece), by Application (Medicine and Others) and major geographies with country level break-up. According to AMA, the Global Bifidobacterium Longum market is expected to see steady growth rate.

BioGaia AB (Sweden), Mystic Pharmaceuticals Inc (United States), Hanson Ltd (United Kingdom), Biofodan A/S (Denmark), BioCare Copenhagen ApS(Denmark), Danisco A/S (Denmark), Danone SA (France) and Deerland Probiotics & Enzymes (United States) are some of the key players profiled in the study.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Bifidobacterium Longum market throughout the forecasted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Bifidobacterium Longum market by Type, Application and Region.

On the basis of geography, the market of Bifidobacterium Longum has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The surge in awareness towards healthy food products
  • The rise in demand for probiotic dietary supplements with probiotic ingredients

Market Trend
  • Increasing online sales channel

Restraints
  • Stringent government regulations

Opportunities
  • Growing use to treat various diseases especially for the treatment of respiratory disorders

Challenges
  • Availability of substitute





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Bifidobacterium Longum Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • 0.2g/Piece
  • 0.25g/Piece
By Application
  • Medicine
  • Others
By Distribution Channel
  • Online
  • Offline

By Varieties
  • Sub-acute experimental
  • Acute

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The surge in awareness towards healthy food products
      • 3.2.2. The rise in demand for probiotic dietary supplements with probiotic ingredients
    • 3.3. Market Challenges
      • 3.3.1. Availability of substitute
    • 3.4. Market Trends
      • 3.4.1. Increasing online sales channel
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bifidobacterium Longum, by Type, Application, Distribution Channel, Varieties and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Bifidobacterium Longum (Value)
      • 5.2.1. Global Bifidobacterium Longum by: Type (Value)
        • 5.2.1.1. 0.2g/Piece
        • 5.2.1.2. 0.25g/Piece
      • 5.2.2. Global Bifidobacterium Longum by: Application (Value)
        • 5.2.2.1. Medicine
        • 5.2.2.2. Others
      • 5.2.3. Global Bifidobacterium Longum by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Bifidobacterium Longum by: Varieties (Value)
        • 5.2.4.1. Sub-acute experimental
        • 5.2.4.2. Acute
      • 5.2.5. Global Bifidobacterium Longum Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Bifidobacterium Longum (Volume)
      • 5.3.1. Global Bifidobacterium Longum by: Type (Volume)
        • 5.3.1.1. 0.2g/Piece
        • 5.3.1.2. 0.25g/Piece
      • 5.3.2. Global Bifidobacterium Longum by: Application (Volume)
        • 5.3.2.1. Medicine
        • 5.3.2.2. Others
      • 5.3.3. Global Bifidobacterium Longum by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Bifidobacterium Longum by: Varieties (Volume)
        • 5.3.4.1. Sub-acute experimental
        • 5.3.4.2. Acute
      • 5.3.5. Global Bifidobacterium Longum Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Bifidobacterium Longum (Price)
      • 5.4.1. Global Bifidobacterium Longum by: Type (Price)
  • 6. Bifidobacterium Longum: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioGaia AB (Sweden)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mystic Pharmaceuticals Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hanson Ltd (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biofodan A/S (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioCare Copenhagen ApS(Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danisco A/S (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danone SA (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Deerland Probiotics & Enzymes (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Bifidobacterium Longum Sale, by Type, Application, Distribution Channel, Varieties and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Bifidobacterium Longum (Value)
      • 7.2.1. Global Bifidobacterium Longum by: Type (Value)
        • 7.2.1.1. 0.2g/Piece
        • 7.2.1.2. 0.25g/Piece
      • 7.2.2. Global Bifidobacterium Longum by: Application (Value)
        • 7.2.2.1. Medicine
        • 7.2.2.2. Others
      • 7.2.3. Global Bifidobacterium Longum by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Bifidobacterium Longum by: Varieties (Value)
        • 7.2.4.1. Sub-acute experimental
        • 7.2.4.2. Acute
      • 7.2.5. Global Bifidobacterium Longum Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Bifidobacterium Longum (Volume)
      • 7.3.1. Global Bifidobacterium Longum by: Type (Volume)
        • 7.3.1.1. 0.2g/Piece
        • 7.3.1.2. 0.25g/Piece
      • 7.3.2. Global Bifidobacterium Longum by: Application (Volume)
        • 7.3.2.1. Medicine
        • 7.3.2.2. Others
      • 7.3.3. Global Bifidobacterium Longum by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Bifidobacterium Longum by: Varieties (Volume)
        • 7.3.4.1. Sub-acute experimental
        • 7.3.4.2. Acute
      • 7.3.5. Global Bifidobacterium Longum Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Bifidobacterium Longum (Price)
      • 7.4.1. Global Bifidobacterium Longum by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bifidobacterium Longum: by Type(USD Million)
  • Table 2. Bifidobacterium Longum 0.2g/Piece , by Region USD Million (2016-2021)
  • Table 3. Bifidobacterium Longum 0.25g/Piece , by Region USD Million (2016-2021)
  • Table 4. Bifidobacterium Longum: by Application(USD Million)
  • Table 5. Bifidobacterium Longum Medicine , by Region USD Million (2016-2021)
  • Table 6. Bifidobacterium Longum Others , by Region USD Million (2016-2021)
  • Table 7. Bifidobacterium Longum: by Distribution Channel(USD Million)
  • Table 8. Bifidobacterium Longum Online , by Region USD Million (2016-2021)
  • Table 9. Bifidobacterium Longum Offline , by Region USD Million (2016-2021)
  • Table 10. Bifidobacterium Longum: by Varieties(USD Million)
  • Table 11. Bifidobacterium Longum Sub-acute experimental , by Region USD Million (2016-2021)
  • Table 12. Bifidobacterium Longum Acute , by Region USD Million (2016-2021)
  • Table 13. South America Bifidobacterium Longum, by Country USD Million (2016-2021)
  • Table 14. South America Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 15. South America Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 16. South America Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 17. South America Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 18. Brazil Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 19. Brazil Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 20. Brazil Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 21. Brazil Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 22. Argentina Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 23. Argentina Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 24. Argentina Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 25. Argentina Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 26. Rest of South America Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 27. Rest of South America Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 28. Rest of South America Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 29. Rest of South America Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 30. Asia Pacific Bifidobacterium Longum, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 34. Asia Pacific Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 35. China Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 36. China Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 37. China Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 38. China Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 39. Japan Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 40. Japan Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 41. Japan Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 42. Japan Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 43. India Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 44. India Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 45. India Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 46. India Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 47. South Korea Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 48. South Korea Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 49. South Korea Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 50. South Korea Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 51. Taiwan Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 52. Taiwan Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 53. Taiwan Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 54. Taiwan Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 55. Australia Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 56. Australia Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 57. Australia Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 58. Australia Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 59. Rest of Asia-Pacific Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 60. Rest of Asia-Pacific Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 63. Europe Bifidobacterium Longum, by Country USD Million (2016-2021)
  • Table 64. Europe Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 65. Europe Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 66. Europe Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 67. Europe Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 68. Germany Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 69. Germany Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 70. Germany Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 71. Germany Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 72. France Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 73. France Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 74. France Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 75. France Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 76. Italy Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 77. Italy Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 78. Italy Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 79. Italy Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 80. United Kingdom Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 81. United Kingdom Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 82. United Kingdom Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 83. United Kingdom Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 84. Netherlands Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 85. Netherlands Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 86. Netherlands Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 87. Netherlands Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 88. Rest of Europe Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 89. Rest of Europe Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 90. Rest of Europe Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 91. Rest of Europe Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 92. MEA Bifidobacterium Longum, by Country USD Million (2016-2021)
  • Table 93. MEA Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 94. MEA Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 95. MEA Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 96. MEA Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 97. Middle East Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 98. Middle East Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 99. Middle East Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 100. Middle East Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 101. Africa Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 102. Africa Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 103. Africa Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 104. Africa Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 105. North America Bifidobacterium Longum, by Country USD Million (2016-2021)
  • Table 106. North America Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 107. North America Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 108. North America Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 109. North America Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 110. United States Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 111. United States Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 112. United States Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 113. United States Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 114. Canada Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 115. Canada Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 116. Canada Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 117. Canada Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 118. Mexico Bifidobacterium Longum, by Type USD Million (2016-2021)
  • Table 119. Mexico Bifidobacterium Longum, by Application USD Million (2016-2021)
  • Table 120. Mexico Bifidobacterium Longum, by Distribution Channel USD Million (2016-2021)
  • Table 121. Mexico Bifidobacterium Longum, by Varieties USD Million (2016-2021)
  • Table 122. Bifidobacterium Longum Sales: by Type(K Units)
  • Table 123. Bifidobacterium Longum Sales 0.2g/Piece , by Region K Units (2016-2021)
  • Table 124. Bifidobacterium Longum Sales 0.25g/Piece , by Region K Units (2016-2021)
  • Table 125. Bifidobacterium Longum Sales: by Application(K Units)
  • Table 126. Bifidobacterium Longum Sales Medicine , by Region K Units (2016-2021)
  • Table 127. Bifidobacterium Longum Sales Others , by Region K Units (2016-2021)
  • Table 128. Bifidobacterium Longum Sales: by Distribution Channel(K Units)
  • Table 129. Bifidobacterium Longum Sales Online , by Region K Units (2016-2021)
  • Table 130. Bifidobacterium Longum Sales Offline , by Region K Units (2016-2021)
  • Table 131. Bifidobacterium Longum Sales: by Varieties(K Units)
  • Table 132. Bifidobacterium Longum Sales Sub-acute experimental , by Region K Units (2016-2021)
  • Table 133. Bifidobacterium Longum Sales Acute , by Region K Units (2016-2021)
  • Table 134. South America Bifidobacterium Longum Sales, by Country K Units (2016-2021)
  • Table 135. South America Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 136. South America Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 137. South America Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 138. South America Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 139. Brazil Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 140. Brazil Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 141. Brazil Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 142. Brazil Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 143. Argentina Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 144. Argentina Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 145. Argentina Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 146. Argentina Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 147. Rest of South America Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 148. Rest of South America Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 149. Rest of South America Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 150. Rest of South America Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 151. Asia Pacific Bifidobacterium Longum Sales, by Country K Units (2016-2021)
  • Table 152. Asia Pacific Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 153. Asia Pacific Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 154. Asia Pacific Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 155. Asia Pacific Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 156. China Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 157. China Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 158. China Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 159. China Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 160. Japan Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 161. Japan Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 162. Japan Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 163. Japan Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 164. India Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 165. India Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 166. India Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 167. India Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 168. South Korea Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 169. South Korea Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 170. South Korea Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 171. South Korea Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 172. Taiwan Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 173. Taiwan Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 174. Taiwan Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 175. Taiwan Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 176. Australia Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 177. Australia Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 178. Australia Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 179. Australia Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 180. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 181. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 182. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 183. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 184. Europe Bifidobacterium Longum Sales, by Country K Units (2016-2021)
  • Table 185. Europe Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 186. Europe Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 187. Europe Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 188. Europe Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 189. Germany Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 190. Germany Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 191. Germany Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 192. Germany Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 193. France Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 194. France Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 195. France Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 196. France Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 197. Italy Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 198. Italy Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 199. Italy Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 200. Italy Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 201. United Kingdom Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 202. United Kingdom Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 203. United Kingdom Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 204. United Kingdom Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 205. Netherlands Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 206. Netherlands Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 207. Netherlands Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 208. Netherlands Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 209. Rest of Europe Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 210. Rest of Europe Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 211. Rest of Europe Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 212. Rest of Europe Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 213. MEA Bifidobacterium Longum Sales, by Country K Units (2016-2021)
  • Table 214. MEA Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 215. MEA Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 216. MEA Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 217. MEA Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 218. Middle East Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 219. Middle East Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 220. Middle East Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 221. Middle East Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 222. Africa Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 223. Africa Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 224. Africa Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 225. Africa Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 226. North America Bifidobacterium Longum Sales, by Country K Units (2016-2021)
  • Table 227. North America Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 228. North America Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 229. North America Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 230. North America Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 231. United States Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 232. United States Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 233. United States Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 234. United States Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 235. Canada Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 236. Canada Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 237. Canada Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 238. Canada Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 239. Mexico Bifidobacterium Longum Sales, by Type K Units (2016-2021)
  • Table 240. Mexico Bifidobacterium Longum Sales, by Application K Units (2016-2021)
  • Table 241. Mexico Bifidobacterium Longum Sales, by Distribution Channel K Units (2016-2021)
  • Table 242. Mexico Bifidobacterium Longum Sales, by Varieties K Units (2016-2021)
  • Table 243. Bifidobacterium Longum: by Type(USD/Units)
  • Table 244. Company Basic Information, Sales Area and Its Competitors
  • Table 245. Company Basic Information, Sales Area and Its Competitors
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Bifidobacterium Longum: by Type(USD Million)
  • Table 253. Bifidobacterium Longum 0.2g/Piece , by Region USD Million (2022-2027)
  • Table 254. Bifidobacterium Longum 0.25g/Piece , by Region USD Million (2022-2027)
  • Table 255. Bifidobacterium Longum: by Application(USD Million)
  • Table 256. Bifidobacterium Longum Medicine , by Region USD Million (2022-2027)
  • Table 257. Bifidobacterium Longum Others , by Region USD Million (2022-2027)
  • Table 258. Bifidobacterium Longum: by Distribution Channel(USD Million)
  • Table 259. Bifidobacterium Longum Online , by Region USD Million (2022-2027)
  • Table 260. Bifidobacterium Longum Offline , by Region USD Million (2022-2027)
  • Table 261. Bifidobacterium Longum: by Varieties(USD Million)
  • Table 262. Bifidobacterium Longum Sub-acute experimental , by Region USD Million (2022-2027)
  • Table 263. Bifidobacterium Longum Acute , by Region USD Million (2022-2027)
  • Table 264. South America Bifidobacterium Longum, by Country USD Million (2022-2027)
  • Table 265. South America Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 266. South America Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 267. South America Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 268. South America Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 269. Brazil Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 270. Brazil Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 271. Brazil Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 272. Brazil Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 273. Argentina Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 274. Argentina Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 275. Argentina Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 276. Argentina Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 277. Rest of South America Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 278. Rest of South America Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 279. Rest of South America Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 280. Rest of South America Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 281. Asia Pacific Bifidobacterium Longum, by Country USD Million (2022-2027)
  • Table 282. Asia Pacific Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 283. Asia Pacific Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 284. Asia Pacific Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 285. Asia Pacific Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 286. China Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 287. China Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 288. China Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 289. China Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 290. Japan Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 291. Japan Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 292. Japan Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 293. Japan Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 294. India Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 295. India Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 296. India Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 297. India Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 298. South Korea Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 299. South Korea Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 300. South Korea Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 301. South Korea Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 302. Taiwan Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 303. Taiwan Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 304. Taiwan Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 305. Taiwan Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 306. Australia Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 307. Australia Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 308. Australia Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 309. Australia Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 310. Rest of Asia-Pacific Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 311. Rest of Asia-Pacific Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 312. Rest of Asia-Pacific Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 313. Rest of Asia-Pacific Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 314. Europe Bifidobacterium Longum, by Country USD Million (2022-2027)
  • Table 315. Europe Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 316. Europe Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 317. Europe Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 318. Europe Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 319. Germany Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 320. Germany Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 321. Germany Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 322. Germany Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 323. France Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 324. France Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 325. France Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 326. France Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 327. Italy Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 328. Italy Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 329. Italy Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 330. Italy Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 331. United Kingdom Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 332. United Kingdom Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 333. United Kingdom Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 334. United Kingdom Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 335. Netherlands Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 336. Netherlands Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 337. Netherlands Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 338. Netherlands Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 339. Rest of Europe Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 340. Rest of Europe Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 341. Rest of Europe Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 342. Rest of Europe Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 343. MEA Bifidobacterium Longum, by Country USD Million (2022-2027)
  • Table 344. MEA Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 345. MEA Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 346. MEA Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 347. MEA Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 348. Middle East Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 349. Middle East Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 350. Middle East Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 351. Middle East Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 352. Africa Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 353. Africa Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 354. Africa Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 355. Africa Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 356. North America Bifidobacterium Longum, by Country USD Million (2022-2027)
  • Table 357. North America Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 358. North America Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 359. North America Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 360. North America Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 361. United States Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 362. United States Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 363. United States Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 364. United States Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 365. Canada Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 366. Canada Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 367. Canada Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 368. Canada Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 369. Mexico Bifidobacterium Longum, by Type USD Million (2022-2027)
  • Table 370. Mexico Bifidobacterium Longum, by Application USD Million (2022-2027)
  • Table 371. Mexico Bifidobacterium Longum, by Distribution Channel USD Million (2022-2027)
  • Table 372. Mexico Bifidobacterium Longum, by Varieties USD Million (2022-2027)
  • Table 373. Bifidobacterium Longum Sales: by Type(K Units)
  • Table 374. Bifidobacterium Longum Sales 0.2g/Piece , by Region K Units (2022-2027)
  • Table 375. Bifidobacterium Longum Sales 0.25g/Piece , by Region K Units (2022-2027)
  • Table 376. Bifidobacterium Longum Sales: by Application(K Units)
  • Table 377. Bifidobacterium Longum Sales Medicine , by Region K Units (2022-2027)
  • Table 378. Bifidobacterium Longum Sales Others , by Region K Units (2022-2027)
  • Table 379. Bifidobacterium Longum Sales: by Distribution Channel(K Units)
  • Table 380. Bifidobacterium Longum Sales Online , by Region K Units (2022-2027)
  • Table 381. Bifidobacterium Longum Sales Offline , by Region K Units (2022-2027)
  • Table 382. Bifidobacterium Longum Sales: by Varieties(K Units)
  • Table 383. Bifidobacterium Longum Sales Sub-acute experimental , by Region K Units (2022-2027)
  • Table 384. Bifidobacterium Longum Sales Acute , by Region K Units (2022-2027)
  • Table 385. South America Bifidobacterium Longum Sales, by Country K Units (2022-2027)
  • Table 386. South America Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 387. South America Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 388. South America Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 389. South America Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 390. Brazil Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 391. Brazil Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 392. Brazil Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 393. Brazil Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 394. Argentina Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 395. Argentina Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 396. Argentina Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 397. Argentina Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 398. Rest of South America Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 399. Rest of South America Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 400. Rest of South America Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 401. Rest of South America Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 402. Asia Pacific Bifidobacterium Longum Sales, by Country K Units (2022-2027)
  • Table 403. Asia Pacific Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 404. Asia Pacific Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 405. Asia Pacific Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 406. Asia Pacific Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 407. China Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 408. China Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 409. China Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 410. China Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 411. Japan Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 412. Japan Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 413. Japan Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 414. Japan Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 415. India Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 416. India Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 417. India Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 418. India Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 419. South Korea Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 420. South Korea Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 421. South Korea Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 422. South Korea Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 423. Taiwan Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 424. Taiwan Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 425. Taiwan Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 426. Taiwan Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 427. Australia Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 428. Australia Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 429. Australia Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 430. Australia Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 431. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 432. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 433. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 434. Rest of Asia-Pacific Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 435. Europe Bifidobacterium Longum Sales, by Country K Units (2022-2027)
  • Table 436. Europe Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 437. Europe Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 438. Europe Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 439. Europe Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 440. Germany Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 441. Germany Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 442. Germany Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 443. Germany Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 444. France Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 445. France Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 446. France Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 447. France Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 448. Italy Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 449. Italy Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 450. Italy Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 451. Italy Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 452. United Kingdom Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 453. United Kingdom Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 454. United Kingdom Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 455. United Kingdom Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 456. Netherlands Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 457. Netherlands Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 458. Netherlands Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 459. Netherlands Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 460. Rest of Europe Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 461. Rest of Europe Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 462. Rest of Europe Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 463. Rest of Europe Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 464. MEA Bifidobacterium Longum Sales, by Country K Units (2022-2027)
  • Table 465. MEA Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 466. MEA Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 467. MEA Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 468. MEA Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 469. Middle East Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 470. Middle East Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 471. Middle East Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 472. Middle East Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 473. Africa Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 474. Africa Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 475. Africa Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 476. Africa Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 477. North America Bifidobacterium Longum Sales, by Country K Units (2022-2027)
  • Table 478. North America Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 479. North America Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 480. North America Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 481. North America Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 482. United States Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 483. United States Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 484. United States Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 485. United States Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 486. Canada Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 487. Canada Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 488. Canada Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 489. Canada Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 490. Mexico Bifidobacterium Longum Sales, by Type K Units (2022-2027)
  • Table 491. Mexico Bifidobacterium Longum Sales, by Application K Units (2022-2027)
  • Table 492. Mexico Bifidobacterium Longum Sales, by Distribution Channel K Units (2022-2027)
  • Table 493. Mexico Bifidobacterium Longum Sales, by Varieties K Units (2022-2027)
  • Table 494. Bifidobacterium Longum: by Type(USD/Units)
  • Table 495. Research Programs/Design for This Report
  • Table 496. Key Data Information from Secondary Sources
  • Table 497. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bifidobacterium Longum: by Type USD Million (2016-2021)
  • Figure 5. Global Bifidobacterium Longum: by Application USD Million (2016-2021)
  • Figure 6. Global Bifidobacterium Longum: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Bifidobacterium Longum: by Varieties USD Million (2016-2021)
  • Figure 8. South America Bifidobacterium Longum Share (%), by Country
  • Figure 9. Asia Pacific Bifidobacterium Longum Share (%), by Country
  • Figure 10. Europe Bifidobacterium Longum Share (%), by Country
  • Figure 11. MEA Bifidobacterium Longum Share (%), by Country
  • Figure 12. North America Bifidobacterium Longum Share (%), by Country
  • Figure 13. Global Bifidobacterium Longum: by Type K Units (2016-2021)
  • Figure 14. Global Bifidobacterium Longum: by Application K Units (2016-2021)
  • Figure 15. Global Bifidobacterium Longum: by Distribution Channel K Units (2016-2021)
  • Figure 16. Global Bifidobacterium Longum: by Varieties K Units (2016-2021)
  • Figure 17. South America Bifidobacterium Longum Share (%), by Country
  • Figure 18. Asia Pacific Bifidobacterium Longum Share (%), by Country
  • Figure 19. Europe Bifidobacterium Longum Share (%), by Country
  • Figure 20. MEA Bifidobacterium Longum Share (%), by Country
  • Figure 21. North America Bifidobacterium Longum Share (%), by Country
  • Figure 22. Global Bifidobacterium Longum: by Type USD/Units (2016-2021)
  • Figure 23. Global Bifidobacterium Longum share by Players 2021 (%)
  • Figure 24. Global Bifidobacterium Longum share by Players (Top 3) 2021(%)
  • Figure 25. Global Bifidobacterium Longum share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. BioGaia AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 28. BioGaia AB (Sweden) Revenue: by Geography 2021
  • Figure 29. Mystic Pharmaceuticals Inc (United States) Revenue, Net Income and Gross profit
  • Figure 30. Mystic Pharmaceuticals Inc (United States) Revenue: by Geography 2021
  • Figure 31. Hanson Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Hanson Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 33. Biofodan A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. Biofodan A/S (Denmark) Revenue: by Geography 2021
  • Figure 35. BioCare Copenhagen ApS(Denmark) Revenue, Net Income and Gross profit
  • Figure 36. BioCare Copenhagen ApS(Denmark) Revenue: by Geography 2021
  • Figure 37. Danisco A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 38. Danisco A/S (Denmark) Revenue: by Geography 2021
  • Figure 39. Danone SA (France) Revenue, Net Income and Gross profit
  • Figure 40. Danone SA (France) Revenue: by Geography 2021
  • Figure 41. Deerland Probiotics & Enzymes (United States) Revenue, Net Income and Gross profit
  • Figure 42. Deerland Probiotics & Enzymes (United States) Revenue: by Geography 2021
  • Figure 43. Global Bifidobacterium Longum: by Type USD Million (2022-2027)
  • Figure 44. Global Bifidobacterium Longum: by Application USD Million (2022-2027)
  • Figure 45. Global Bifidobacterium Longum: by Distribution Channel USD Million (2022-2027)
  • Figure 46. Global Bifidobacterium Longum: by Varieties USD Million (2022-2027)
  • Figure 47. South America Bifidobacterium Longum Share (%), by Country
  • Figure 48. Asia Pacific Bifidobacterium Longum Share (%), by Country
  • Figure 49. Europe Bifidobacterium Longum Share (%), by Country
  • Figure 50. MEA Bifidobacterium Longum Share (%), by Country
  • Figure 51. North America Bifidobacterium Longum Share (%), by Country
  • Figure 52. Global Bifidobacterium Longum: by Type K Units (2022-2027)
  • Figure 53. Global Bifidobacterium Longum: by Application K Units (2022-2027)
  • Figure 54. Global Bifidobacterium Longum: by Distribution Channel K Units (2022-2027)
  • Figure 55. Global Bifidobacterium Longum: by Varieties K Units (2022-2027)
  • Figure 56. South America Bifidobacterium Longum Share (%), by Country
  • Figure 57. Asia Pacific Bifidobacterium Longum Share (%), by Country
  • Figure 58. Europe Bifidobacterium Longum Share (%), by Country
  • Figure 59. MEA Bifidobacterium Longum Share (%), by Country
  • Figure 60. North America Bifidobacterium Longum Share (%), by Country
  • Figure 61. Global Bifidobacterium Longum: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • BioGaia AB (Sweden)
  • Mystic Pharmaceuticals Inc (United States)
  • Hanson Ltd (United Kingdom)
  • Biofodan A/S (Denmark)
  • BioCare Copenhagen ApS(Denmark)
  • Danisco A/S (Denmark)
  • Danone SA (France)
  • Deerland Probiotics & Enzymes (United States)
Select User Access Type

Key Highlights of Report


May 2022 246 Pages 67 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bifidobacterium Longum Market Quantitative research analysis
Global Bifidobacterium Longum Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The surge in awareness towards healthy food products " is seen as one of major growth factors of Bifidobacterium Longum Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Bifidobacterium Longum Market in coming years.

Know More About Global Bifidobacterium Longum Market Report?

Have a Query? Click Here

Other Related Reports

Post Acute Care Comprehensive Study by Type (Skilled Nursing Facilities, Home Health, Long Term Acute Care Hospitals, Inpatient Rehabilitation Facilities), Application (Child, Adult, Elderly) Players...
$ 3500
Aphakia Comprehensive Study by Type (Primary, Secondary), Treatment (Spectacles, Contact Lenses, Intraocular Lens Implantation, Refractive Surgery), Intraocular Lens Material (PMMA, Silicon, Hydrogel...
$ 3650
Physical Examination Comprehensive Study by Type (Routine Physical Examination, Comprehensive Physical Examination, Others), Application (Enterprises, Individuals), End Use (Hospitals, Clinics, Other...
$ 3500
Myelofibrosis Comprehensive Study by Type (Gene Mutation Analysis, Bone Marrow Biopsy, Imaging Tests, Blood Tests), Treatement (Chemotherapy, Blood Transfusions, Stem Cell Transplant, Splenectomy, Ra...
$ 3450
Adenoid Cystic Carcinom Comprehensive Study by By Test Type (Magnetic resonance imaging, Computerized tomography, Positron emission tomography), Grade type (Tubular, Cribriform, Solid), Age Group (Ch...
$ 3450
Healthcare Contract Research Organization Comprehensive Study by Type (Early Phase development, Clinical research, Laboratory regulatory Consulting), Therapeutic Areas (Oncology, CNS Disorder, Cardio...
$ 3750